Home / Companies / 10X Genomics, Inc. / 11 Jun 2024
10X Genomics, Inc.: meeting of 11 Jun 2024
Votes reported on Form N-PX, item by item
470 Form N-PX filers reported votes at the 10X Genomics, Inc. meeting of 11 Jun 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
1 nominee; 62.8% of reported votes for; 62 filers withheld from or voted against at least one nominee.
284 vote records from 150 filers. 56 of the 149 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
666 vote records from 464 filers. 279 of the 444 filers that marked the item either way voted against management. 20 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
283 vote records from 149 filers. 0 of the 148 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
0 filers reported share counts too large to be the holding described. No share split is published for this item. How that is decided
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
282 vote records from 148 filers. 110 of the 147 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | Against * | For |
| Fidelity | For | For | For |
| Dimensional | Against * | Against * | For |
| State Street and SPDR | For | For | For |
| American Century | Against * | Against * | For |
| Franklin Templeton | For | Against * | For |
| Invesco | For | Against * | For |
| Equitable | For | For | For |
| Charles Schwab | For | Against * | For |
| Nuveen and TIAA | Against * | Against * | For |
| ProShares and ProFunds | Against * | Against * | For |
| John Hancock and Manulife | Against * | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For | For |
| J.P. Morgan | For | Against * | For |
| Goldman Sachs | Against * | Against * | For |
| PGIM and Prudential | Against * | Against * | For |
| Jackson National funds | Against * | Against * | For |
| Northern Trust and FlexShares | For | For | For |
| SEI | For | Against * | For |
| T. Rowe Price | Against * | Against * | For |
| Lincoln Financial | For | Against * | For |
| Voya | For | For | For |
| First Trust | Against * | Against * | For |
| Russell Investments | For | Against * | For |
| Nationwide | For | Against * | For |
| Victory Capital | Against * | Against * | For |
| Brighthouse Funds | For | For | For |
| Columbia Threadneedle | For | For | For |
| BNY Mellon | Against * | Against * | For |
| Principal | Against * | Against * | For |
| Capital Group and American Funds | For | Against * | For |
| Pacific Life funds | For | Against * | For |
| Global X | For | Against * | For |
| Transamerica | For | For | For |
| Federated Hermes | No report | Against * | No report |
| AllianceBernstein | No report | Against * | No report |
| DWS | No report | Against * | No report |
| Allspring | No report | Against * | No report |
| MassMutual | For | For | For |
| Janus Henderson | No report | Against * | No report |
| Neuberger Berman | No report | Against * | No report |
| American Beacon | For | For | For |
| Natixis and Loomis Sayles | No report | Against * | No report |
| Lord Abbett | Against * | Against * | For |
| Harris Associates and Oakmark | No report | For | No report |
| Baird | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the 10X Genomics, Inc. meeting?
470 Form N-PX filers reported votes at the meeting of 11 Jun 2024. On say-on-pay, 279 of 444 voted against management (62.8%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by 10X Genomics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for 10X Genomics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing 10X Genomics, Inc. with a meeting date within three days of 11 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.